OncoDaily appoints Jo Sawyer as Vice President of Strategic Partnerships and Industry Relations
Reed Jobs’ Yosemite Raises $350 Million to Support Cancer Research
Seismic Shift: Innovations in MRD Testing and Pathology
OncoMovie: The Fault in Our Stars – Emotional Cancer Story and Ending Explained
TALAPRO-2 Biomarker Analysis: ctDNA and CTC Changes as Prognostic Markers in mCRPC
Bladder Cancer, Quality of Life, and the Power of Digital Advocacy
Sami Mansfield: ESMO 2026 and Lifestyle Medicine - Missing, or Opportunity?
Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
